All Articles

Retail credit regulation and health data governance rarely share a headline, but both now turn on the same unresolved question about outsourcing the core relationship an institution exists to hold.

Why NHS England's Waqar Iqbal Has Become the Secret Power Indispensable to the System.

Clinicians and managers were aware of failures in a Kent ear, nose and throat service half a decade before the scale of the problem emerged, an NHS England investigation concludes, reviving questions about how oversight systems fail to catch harm in plain sight.

Redirecting private profits into municipal care provision could stabilise Britain's fragile social care network as the Casey review moves onto an accelerated timetable.

As France repurposes its mail network to check on isolated pensioners during extreme heat, the absence of any comparable system in the UK exposes how far social care has been allowed to erode.

The disclosure that leading American AI models breached outside organisations during routine testing exposes a governance vacuum that British health leaders can no longer treat as somebody else's problem.

Trust boards warned over patient safety as national oversight of automated clinical notes is relaxed.

A trust's candid admission that scheduling software is simply unavailable in the market reveals how much of Whitehall's efficiency planning depends on technology that has not yet been built.

Elaine Baylis takes over as chair at Nottingham University Hospitals as the trust works to rebuild trust after its maternity failings.

The quiet closure of the Medical Training Initiative says less about workforce planning than about which arguments a stretched health service is willing to make in public.

What one trust group's digital strategy reveals about the real state of NHS modernisation, and why the gap between fixing the basics and promising the future has become a defining tension in health policy.

A regulator's censure of NHS England's Palantir claims lands just as a contractual break clause, a change of technology leadership and a headline funding figure all come due within months of each other.

Two years after rejecting the first drugs shown to delay Alzheimer's disease, the rationing body's methodological reversal exposes how negotiable its own economics can become, and what that might cost the NHS when the next expensive treatment arrives.

A Prime Minister who spent a decade arguing social care was the missing half of NHS recovery now has to prove it with his own government's finances, not someone else's.

Dr Richard Jenkins expands his dual-chief executive role to include a 12-month interim post at Doncaster and Bassetlaw, aiming to strengthen regional healthcare delivery.

As health-tech innovators secure major capital to transform patient diagnostics, the medical sector must grapple with the profound security implications of increasingly independent artificial intelligence.

A new international framework for responsible AI in medicine arrives just as Britain's own regulatory answer remains unwritten.

As global HIV funding collapses under the weight of aid cuts, the NHS is fighting a quieter version of the same battle: turning a scientific breakthrough into something a patient can actually receive.

Investigation into executive culture at Mersey Care NHS Foundation Trust describes a divisive environment that undermined governance and silenced concerns from within.

New six-hour bed clearance orders assume a reserve of capacity that years of occupancy pressure have already spent.